Literature DB >> 5019220

Influence of route of administration on drug availability.

M Rowland.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 5019220     DOI： 10.1002/jps.2600610111

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  93 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Pharmacokinetics of diphenhydramine in man.

Authors:  K S Albert; M R Hallmark; E Sakmar; D J Weidler; J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

3.  Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

4.  Oral bioavailability of omeprazole before and after chronic therapy in patients with duodenal ulcer.

Authors:  M S Ching; G W Mihaly; P W Angus; D J Morgan; S Devenish-Meares; N D Yeomans; R A Smallwood
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

5.  Use of dried blood spots in drug development: pharmacokinetic considerations.

Authors:  Malcolm Rowland; Gary T Emmons
Journal:  AAPS J       Date:  2010-04-10       Impact factor: 4.009

6.  Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.

Authors:  Huadong Sun; K Sandy Pang
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

7.  On the pharmacokinetics of phenacetin in man.

Authors:  J Raaflaub; U C Dubach
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

8.  Kinetics of ajmaline disposition and pharmacologic response in beagle dogs.

Authors:  M Yasuhara; Y Hashimoto; K Okumura; R Hori; T Sakurai; C Kawai
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

9.  Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.

Authors:  J H Jonkman; J Wijsbeek; R A De Zeeuw; L E Van Bork; N G Orie
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

10.  Influence of renal failure on the hepatic clearance of bufuralol in man.

Authors:  L Balant; R J Francis; T N Tozer; A Marmy; J M Tschopp; J Fabre
Journal:  J Pharmacokinet Biopharm       Date:  1980-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.